In datasets derived from the Affymetrix gene chips (Fig. 2A), higher expression of BTN3A1 was associated with better prognosis in breast cancer, ovarian cancer, gastric cancer, and NSCLC. The gene discussed is BTN3A1; the disease is breast cancer.